Cargando…

Preliminary investigation of drug impurities associated with the anti-influenza drug Favipiravir – An insilico approach

The role of repurposed or modified antiviral drugs has become more significant during the current global pandemic of SARS Covid-19. In the present study, four structurally analogous impurity molecules of antiviral drug Favipiravir are selected for preliminary computational investigation for assessin...

Descripción completa

Detalles Bibliográficos
Autores principales: Anil Kumar, S., Bhaskar, B.L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier B.V. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8285362/
https://www.ncbi.nlm.nih.gov/pubmed/34306990
http://dx.doi.org/10.1016/j.comptc.2021.113375
_version_ 1783723546353074176
author Anil Kumar, S.
Bhaskar, B.L.
author_facet Anil Kumar, S.
Bhaskar, B.L.
author_sort Anil Kumar, S.
collection PubMed
description The role of repurposed or modified antiviral drugs has become more significant during the current global pandemic of SARS Covid-19. In the present study, four structurally analogous impurity molecules of antiviral drug Favipiravir are selected for preliminary computational investigation for assessing the structure-activity relationship. The optimized geometry and the electronic structures of the compounds are computed using Density Functional Theory as a precursor to evaluating their physical, chemical and spectral properties. The frontier orbitals analysis is performed to obtain global reactivity parameters namely, the chemical potential, absolute electronegativity, global softness, global hardness, electrophilicity, etc. The natural Bond Orbital (NBO) analysis and Mulliken analysis provided an understanding of the charge-transfer interactions of molecules. The possibilities of intermolecular interactions of the drug systems with the receptors are also visualized using the electrostatic potential maps (MEP) derived from the DFT computations. The physiochemical properties are assessed computationally using SwissADME webtool to correlate the structural aspects of the compounds with their biological responses. Useful parameters namely flexibility, lipophilicity, size, polarity, solubility and saturation were also computed to evaluate the therapeutic activity or drug-likeness.
format Online
Article
Text
id pubmed-8285362
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Elsevier B.V.
record_format MEDLINE/PubMed
spelling pubmed-82853622021-07-20 Preliminary investigation of drug impurities associated with the anti-influenza drug Favipiravir – An insilico approach Anil Kumar, S. Bhaskar, B.L. Comput Theor Chem Article The role of repurposed or modified antiviral drugs has become more significant during the current global pandemic of SARS Covid-19. In the present study, four structurally analogous impurity molecules of antiviral drug Favipiravir are selected for preliminary computational investigation for assessing the structure-activity relationship. The optimized geometry and the electronic structures of the compounds are computed using Density Functional Theory as a precursor to evaluating their physical, chemical and spectral properties. The frontier orbitals analysis is performed to obtain global reactivity parameters namely, the chemical potential, absolute electronegativity, global softness, global hardness, electrophilicity, etc. The natural Bond Orbital (NBO) analysis and Mulliken analysis provided an understanding of the charge-transfer interactions of molecules. The possibilities of intermolecular interactions of the drug systems with the receptors are also visualized using the electrostatic potential maps (MEP) derived from the DFT computations. The physiochemical properties are assessed computationally using SwissADME webtool to correlate the structural aspects of the compounds with their biological responses. Useful parameters namely flexibility, lipophilicity, size, polarity, solubility and saturation were also computed to evaluate the therapeutic activity or drug-likeness. Elsevier B.V. 2021-10 2021-07-17 /pmc/articles/PMC8285362/ /pubmed/34306990 http://dx.doi.org/10.1016/j.comptc.2021.113375 Text en © 2021 Elsevier B.V. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Article
Anil Kumar, S.
Bhaskar, B.L.
Preliminary investigation of drug impurities associated with the anti-influenza drug Favipiravir – An insilico approach
title Preliminary investigation of drug impurities associated with the anti-influenza drug Favipiravir – An insilico approach
title_full Preliminary investigation of drug impurities associated with the anti-influenza drug Favipiravir – An insilico approach
title_fullStr Preliminary investigation of drug impurities associated with the anti-influenza drug Favipiravir – An insilico approach
title_full_unstemmed Preliminary investigation of drug impurities associated with the anti-influenza drug Favipiravir – An insilico approach
title_short Preliminary investigation of drug impurities associated with the anti-influenza drug Favipiravir – An insilico approach
title_sort preliminary investigation of drug impurities associated with the anti-influenza drug favipiravir – an insilico approach
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8285362/
https://www.ncbi.nlm.nih.gov/pubmed/34306990
http://dx.doi.org/10.1016/j.comptc.2021.113375
work_keys_str_mv AT anilkumars preliminaryinvestigationofdrugimpuritiesassociatedwiththeantiinfluenzadrugfavipiraviraninsilicoapproach
AT bhaskarbl preliminaryinvestigationofdrugimpuritiesassociatedwiththeantiinfluenzadrugfavipiraviraninsilicoapproach